Statins and risk of cataracts: A systematic review and meta‐analysis of observational studies
- 29 December 2018
- journal article
- review article
- Published by Wiley in Cardiovascular Therapeutics
- Vol. 36 (6) , e12480
Abstract
Summary: Introduction: Two previous meta‐analyses evaluated the risk of cataracts associated with statins, but did not include relevant studies suggesting a cataractogenic effect.Aims: The aim of this systematic review and meta‐analysis of observational studies is to evaluate such association considering the latest published evidence.Methods: A literature search was conducted to identify observational, comparative studies evaluating the risk of developing cataracts in patients treated with statins. A meta‐analysis was performed to estimate odds ratios (ORs). Results were stratified according to the following studies’ subgroups: design, methodological quality, method of diagnosis of cataract, patients’ age, and median follow‐up. Meta‐regressions evaluated the influence of the following risk factors: smoking, hypertension, corticosteroids, selective serotonin reuptake inhibitors (SSRI), diabetes mellitus, and cardiovascular disease.Results: Twenty‐one studies were included. Treatment with statins was associated with an increased risk of cataracts [OR: 1.11 (95% CI: 1.02‐1.21); P = 0.017; I2 = 97.5%]. This risk remained statistically significant among case‐controls, good methodological quality studies, studies with length of follow‐up ≥5 years and those which outcome was cataract surgery. Between‐studies heterogeneity was high among all risk estimates. Meta‐regressions identified an inverse relationship between the risk of cataracts and the proportion of diabetic patients in the studies.Conclusions: The results point out an increased risk of cataract development with statins. However, since the magnitude of the effect is low and between‐studies heterogeneity is high, the extent in which these results have impact on the benefit/risk ratio of statins is difficult to ascertain due to the uncertainty of the findings.Keywords
This publication has 64 references indexed in Scilit:
- Cataract research using electronic health recordsBMC Ophthalmology, 2011
- Data sources on drug safety evaluation: a review of recent published meta-analysesPharmacoepidemiology and Drug Safety, 2011
- Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trialsThe Lancet, 2010
- Unintended effects of statins in men and women in England and Wales: population based cohort study using the QResearch databaseBMJ, 2010
- The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trialsBMJ, 2009
- Indications for Propensity Scores and Review of their Use in PharmacoepidemiologyBasic & Clinical Pharmacology & Toxicology, 2006
- Risk of cardiovascular events and rofecoxib: cumulative meta-analysisThe Lancet, 2004
- Measuring inconsistency in meta-analysesBMJ, 2003
- Lens changes in matched normals and hyperlipidemic patients treated with simvastatin for 2 yearsActa Ophthalmologica, 1990
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986